• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CURONIX LLC FREEDOM PERIPHERAL NERVE STIMULATOR; TRANSMITTER ASSEMBLY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CURONIX LLC FREEDOM PERIPHERAL NERVE STIMULATOR; TRANSMITTER ASSEMBLY Back to Search Results
Model Number PDBT-915-2K
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Electric Shock (2554)
Date of Event 10/06/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The transmitter assembly was received at curonix headquarters for investigation on october 17, 2023.The investigation of the device was unable to replicate the alleged issue, and no nonconformances were found.The unintended stimulation/new pain questionnaire was reviewed for potential causes of the reported issue.Based on this review, the waa providing therapy when unintended stimulation occurred, the patient having another non-curonix device implanted, changing the waa parameters intentionally or unintentionally, and the patient experiencing unintended stimulation in a new area that is not targeted for therapy have been ruled out as potential causes.The stimulator is used to treat pain.The cause of the unintended stimulation is unknown.Therefore, conclusion has been selected as no problem/fault found.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in unintended stimulation/new pain issues.Unintended stimulation/new pain issue rates remain acceptably low; thus, capa is not required. unintended stimulation/new pain issue rates will continue to be tracked and trended.
 
Event or Problem Description
The patient reported feeling a jolting sensation from the transmitter but not the antenna.The patient is using their other transmitter assembly (set at the same parameters) with no complaints.No additional adverse events or complications have been reported and the patient continues to have 80% relief.Additionally, the patient was provided a replacement transmitter assembly.
 
Event or Problem Description
The patient reported feeling a jolting sensation from the transmitter but not the antenna.The patient is using their other transmitter assembly (set at the same parameters) with no complaints.No additional adverse events or complications have been reported and the patient continues to have 80% relief.Additionally, the patient was provided a replacement transmitter assembly.
 
Additional Manufacturer Narrative
The transmitter assembly was received at curonix headquarters for investigation on october 17, 2023.The investigation of the device was unable to replicate the alleged issue, and no nonconformances were found.The unintended stimulation/new pain questionnaire was reviewed for potential causes of the reported issue.Based on this review, the waa providing therapy when unintended stimulation occurred, the patient having another non-curonix device implanted, changing the waa parameters intentionally or unintentionally, and the patient experiencing unintended stimulation in a new area that is not targeted for therapy have been ruled out as potential causes.The stimulator is used to treat pain.The cause of the unintended stimulation is unknown.The investigation findings do not lead to a clear conclusion about the cause of the reported issue.Therefore, conclusion has been selected as unable to determine root cause.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in unintended stimulation/new pain issues.Unintended stimulation/new pain issue rates remain acceptably low; thus, capa is not required. unintended stimulation/new pain issue rates will continue to be tracked and trended.Updated per fda capa-2023-0013 correction 2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREEDOM PERIPHERAL NERVE STIMULATOR
Common Device Name
TRANSMITTER ASSEMBLY
Manufacturer (Section D)
CURONIX LLC
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer (Section G)
CURONIX LLC
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer Contact
alicia pagliaro
1310 park central boulevard s.
pompano beach, FL 33064
8009655134
MDR Report Key18057882
Report Number3010676138-2023-00225
Device Sequence Number5954704
Product Code GZF
UDI-Device Identifier00818225020150
UDI-Public(01)00818225020150
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K171366
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberPDBT-915-2K
Device Lot Number00794-DT
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/17/2023
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/06/2023
Supplement Date Received by Manufacturer10/06/2023
Initial Report FDA Received Date11/02/2023
Supplement Report FDA Received Date04/26/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/23/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SN: (B)(6), LN:SWO230116, PN:STQ4-RCV-A0; SN: (B)(6), LN:SWO230116, PN:STQ4-RCV-A0
Patient Age84 YR
Patient SexFemale
-
-